RESEARCH PAPER
Influence of amygdalin on genes expression of childhood B and T acute lymphoblastic leukemia cell lines
 
More details
Hide details
1
Independent Laboratory of Genetic Diagnostics, Medical University, Lublin, Poland
 
2
Laboratory of Systems Biology, Faculty of Biology, University of Warsaw, Poland
 
3
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
 
4
Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky National Medical University, Lviv, Ukraine
 
5
Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, Poland
 
 
Corresponding author
Katarzyna Wojciechowska   

Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, Lublin, Poland
 
 
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
B and T acute lymphoblastic leukemias (ALL) are the most common malignancies in children. In recent years, thanks to advances in the field of pharmacology and genetics, the 5-year survival rate for children and adolescents suffering from ALL has improved to more than 90%. However, because of toxicities and adverse effects of current treatment, the incorporations of novel therapeutic approaches are needed to enhance the quality of life of patients. Recent studies reveal that amygdalin is a potent inhibitor of cell growth in bladder, breast, pancreatic, prostate cancer, and renal cell carcinoma cell lines. The aim of the study is to assess the influence of amygdalin on the expression of different genes in B and T acute lymphoblastic leukemia cell lines.

Material and methods:
B-ALL CCRF-HSB-2 [CCRF HSB-2, HSB-2] CCL-102.1 cell line and T- ALL CCRF-SB [CCRF-SB] CCL120 cell line were cultured and treated with amygdalin in concentration of 5 mg/ml and 10 mg/ml. Clariom S human array was used to evaluate the expression of genes. Microarray data were analyzed using Transcriptome Analysis Console 4.0, following the TAC user guide.

Results:
The results show that exposing tumour cells of T- ALL CCRF-SB cell line to amygdalin led to down-regulation in concentration-dependent manner a.o. of MYC, BCL2, ID1, HRAS, NOTCH1 pathway, PI3K/AKT pathway. In stimulated with amygdalin B-ALL CCRF-HSB-2 cell line downregulation of a.o. CRKL and EZH2 genes was observed.

Conclusions:
The study provides the first insight into the potential influence of amygdalin on childhood acute lymphoblastic leukemia cell lines.
REFERENCES (25)
1.
Tran TH, Hunger SP. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol. 2022;84:144–152. doi:10.1016/j.semcancer.2020.10.013.
 
2.
Malczewska, M, Kośmider K, Bednarz K, et al. Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia. Cancers (Basel). 2022;14(8):2021. doi:10.3390/cancers14082021.
 
3.
Rahiman EA, Rajendran A, Sankhyan N, et al. Acute neurological complications during acute lymphoblastic leukemia therapy: A single-center experience over 10 years. Indian J Cancer. 2021;58(4):545–552. doi:10.4103/ijc.IJC42219.
 
4.
Śliwa-Tytko P, Kaczmarska A, Lejman M, et al. Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy. Int J Mol Sci. 2022;23(10):5515. doi:10.3390/ijms23105515.
 
5.
Dorr RT, Paxinos J. The current status of laetrile. Ann Inter Med. 1978;89(3):389–97. doi:10.7326/0003-4819-89-3-389.
 
6.
Jaszczak-Wilke E, Polkowska Ż, Koprowski M, et al. Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds. Molecules. 2021;26:2253. doi:10.3390/molecules26082253.
 
7.
Chang HK, Shin MS, Yang HY, et al. Amygdalin Induces Apoptosis Through Regulation of Bax and Bcl-2 Expressions in Human Du145 and Lncap Prostate Cancer Cells. Biol Pharm Bull. 2006;29:1597–1602. doi:10.1248/bpb.29.1597.
 
8.
Song Z, Xu X. Advanced Research on Anti-tumour Effects of Amygdalin. J Cancer Res. 2014;10:3. doi:10.4103/0973-1482.139743.
 
9.
Makarevic J, Rutz J, Juengel E, et al. Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2. PLoS ONE. 2014;9:e105590. doi:10.1371/journal.pone.0105590.
 
10.
Juengel E, Thomas A, Rutz J, et al. Amygdalin inhibits the growth of renal cell carcinoma cells in vitro. Int J Mol Med. 2016;37:526–532. doi:10.3892/ijmm.2015.2439.
 
11.
Aamazadeh F, Ostadrahimi A, Rahbar Saadat Y, et al. Bitter apricot ethanolic extract induces apoptosis through increasing expression of Bax/Bcl-2 ratio and caspase-3 in PANC-1 pancreatic cancer cells. Mol Biol Rep. 2020;47:1895–1904. doi:10.1007/s11033-020-05286-w.
 
12.
Tsaur I, Thomas A, Monecke M, et al. Amygdalin Exerts Antitumour Activity in Taxane-Resistant Prostate Cancer Cells. Cancers (Basel). 2022;14(13):3111. doi:10.3390/cancers14133111.
 
13.
Saleem M, Asif J, Asif M, et al. Amygdalin from Apricot Kernels Induces Apoptosis and Causes Cell Cycle Arrest in Cancer Cells: An Updated Review. Anticancer Agents Med Chem. 2018;18(12):1650–1655. doi:10.2174/1871520618666180105161136.
 
14.
Tremblay CS, Saw J, Yan F, et al. Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia. Leukemia. 2025;39(3):577–589. doi:10.1038/s41375-024-02491-5.
 
15.
Lyu A, Nam SH, Humphrey RS, et al. Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL). Exp Mol Med. 2024;56(11):2337–2347. doi:10.1038/s12276-024-01335-7.
 
16.
Sergio I, Varricchio C, Squillante F, et al. Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci. 2024;25(23):12839. doi:10.3390/ijms252312839.
 
17.
Xie P, Yu M, Zhang B, et al. CRKL dictates anti-PD-1 resistance by mediating tumour-associated neutrophil infiltration in hepatocellular carcinoma. J Hepatol. 2024;81(1):93–107. doi:10.1016/j.jhep.2024.02.009.
 
18.
Kaur P, Shankar E, Gupta S. EZH2-mediated development of therapeutic resistance in cancer. Cancer Lett. 2024;586:216706. doi:10.1016/j.canlet.2024.216706.
 
19.
Lee H M, Moon A. Amygdalin regulates apoptosis and adhesion in Hs578T triple-negative breast cancer cells. Biomol Ther (Seoul). 2016;24:62–6. doi:10.4062/biomolther.2015.172.
 
20.
Barakat H, Aljutaily T, Almujaydil M, et al. Amygdalin: A Review on Its Characteristics, Antioxidant Potential, Gastrointestinal Microbiota Intervention, Anticancer Therapeutic and Mechanisms, Toxicity, and Encapsulation. Biomolecules. 2022;12(10):1514. doi:10.3390/biom12101514.
 
21.
Albogami S, Alnefaie A. Role of Amygdalin in Blocking DNA Replication in Breast Cancer In Vitro. Curr Pharm Biotechnol. 2021;22:1612–1627. doi:10.2174/1389201022666210203123803.
 
22.
Mosayyebi B, Mohammadi L, Kalantary-Charvadeh A, et al. Amygdalin Decreases Adhesion and Migration of MDA-MB-231 and MCF-7 Breast Cancer Cell Lines. Curr Mol Pharmacol. 2021;14:667–675. doi:10.2174/1874467213666200810141251.
 
23.
Mani J, Neuschafer J, Resch C, et al. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro. Nutr Cancer. 2020;72:528–537. doi:10.1080/01635581.2019.1637442.
 
24.
Lin S, Wen J, Xu X, et al. Amygdalin Induced Mitochondria-Mediated Apoptosis of Lung Cancer Cells via Regulating NF B Signaling Cascade in Vitro and in Vivo. Am J Chin Med. 2022;50:1361–1386. doi:10.1142/S0192415X22500586.
 
25.
Liczbiński P, Bukowska B. Molecular mechanism of amygdalin action in vitro: review of the latest research. Immunopharmacol Immunotoxicol. 2018;40:212–218. doi:10.1080/08923973.2018.1441301.
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top